Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: Long-term follow-up

European Journal of Gynaecological Oncology

Volumn 27, Issue 3, 2006, Pages 231-235

  Argenta, P A ^a,b   Ghebre, R ^a   Dusenbery, K E ^a   Chen, M D ^a   Judson, P L ^a   Downs Jr , L S ^a   Carson, L F ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MMC 395 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; CYTOLOGY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FISTULA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; OBSTRUCTION; RADIATION DOSE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 33745438951     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E. et al.: "Cancer Statistics, 2004". CA Cancer J. Clin., 2004, 54, 2,
2. rd, Shingleton H.M., Blessing J.A.: "Hydroxyurea or placebo combined with radiation to treat Stages IIIB and IV cervical cancer confined to the pelvis". Int. J. Radiat. Oncol. Biol. Phys., 1979, 5, 317.
3. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. et al.: "Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy of bulky Stage IB cervical carcinoma". N. Engl. J. Med., 1999, 340, 1154.
4. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C. et al.: "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study". J. Clin. Oncol., 1999, 17, 1339.
5. Morris Mitchell M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer". N. Engl. J. Med., 1999, 340, 1137.
6. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M. A. et al.: "Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer". N. Engl. J. Med., 1999, 340, 1144.
7. nd, Stock R.J., Monk B.J., Berek J.S. et al.: "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix". J. Clin. Oncol., 2000, 18, 1606.
8. Radovitch E., Fyles A.W., Pintilie M., Leung P.M.: "Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix". Int. J. Radiat. Oncol. Biol. Phys., 1997, 38, 979.
9. Grigsby P.W., Heydon K., Mutch D.G., Kim R.Y., Eifel P.: "Long-term follow-up of RTOG 92-10: cervical cancer with positive paraaortic lymph nodes". Int. J. Radiat. Oncol. Biol. Phys., 2001, 51, 982.
10. Berclaz G., Gerber E., Beer K., Aebi S., Greiner R., Dreher E., Buser K.: "Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-year survival after radiochemotherapy" . Int. J. Oncol., 2002, 20, 1313.
11. Grigsby P.W.: "Prospective phase I/II study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy". Int. J. Gynecol. Cancer, 2004, 14, 860.
12. Chen M.D., Paley P.J., Polish R.A., Twiggs L.B.: "Phase I trial of paclitaxel as a radiation sensitizer with cisplatin in advanced cervical cancer". Gynecol. Oncol., 1997, 67, 131.
13. Park T.K.: "Adjuvant therapy in cervical cancer patients with high risk factors". Yonsei Med. J., 1997, 38, 255.
14. rd, Liu PY. et al.: "Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial". Gynecol. Oncol., 2005, 96, 721.
15. McGuire W.P., Blessing J.A., Moore D., Lentz S.S., Photopulos G.: "Paclitaxel has moderate activity in squamous cervical cancer: a Gynecologic Oncology Group study". J. Clin. Oncol., 1996, 14, 792.
16. Liebmann J., Cook J.A., Fisher J., Teague D., Mitchell J.B.: "In vitro studies of paclitaxel as a radiation sensitizer in human tumor cells". J. Natl. Cancer Inst., 1994, 86, 441.
17. Tishler R.B., Geard C.R., Hall E.J., Schiff P.B.: "Paclitaxel sensitizes human astrocytoma cells to radiation". Cancer Res., 1992, 52, 3495.
18. Steren A., Sevin B.U., Perras J., Angioli R., Nguyen H., Guerra L. et al.: "Paclitaxel sensitizes human ovarian cancer cells to radiation". Gynecol. Oncol., 1993, 48, 252.
19. Jaakkola M., Rantanen V., Grenman S., Kulmala J., Grenman R.: "In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma lines". Cancer, 1996, 77, 1940.
20. Rodriguez M., Sevin B.U., Perras J., Nguyen H.N., Pham C., Steren A.J. et al.: "Paclitaxel: a radiation sensitizer of human cervical cancer cells". Gynecol. Oncol., 1995, 57, 165.
21. Geard C.R., Jones J.M.: "Radiaiton and Paclitaxel effects on synchronized human cancer cells". Int. J. Radiat. Biol. Phys., 1994, 29, 565.
22. Erlich E., McCall A.R., Potkul R.K., Walter S., Vaughan A.: "Paclitaxel is only a weak radiosensitizer of human cervical cancer cell lines". Gynecol. Oncol., 1996, 60, 251.
23. Moore D.H., Blessing J.A., McQuellon R.P., Thaler H.T., Cella D., Benda J. et al.: "Phase III study of cisplatin with or without paclitaxel in Stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study". J. Clin. Oncol., 2004, 22, 3113.
24. Goff B.A., Muntz H.G., PAley P.J., Tamimi H.K., Koh W.J., Greeer B.E.: "Impact of surgical staging in women with locally advanced cervical cancer". Gynecol. Oncol., 1999, 74, 436.
25. Hasenburg A., Salama J.K., Van T.J., Amosson C., Chiu J.K., Kieback D.G.: "Evaluation of patients after exptraperitoneal lymph node dissection and subsequent radiation". Gynecol. Oncol., 2002, 84, 321.
26. Cosin J.A., Fowler J.M., Chen M.D., Paley P.J., Carson L.F., Twiggs L.B.: "Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking". Cancer, 1998, 82, 2241.
27. Zorlu C.G., Aydogdu T., Ergun Y., Kuscu E., Cobanoglu O., Kocak S.: "Complications of radical hysterectomy: Clinical experience of 115 early stage cervical cancers". Gynecol. Obstet. Invest., 1998, 45, 137.
28. Uno T., Ito H., Itami J., Yasuda S., Isobe K., Hara R. et al.: "Post-operative radiation therapy for Stage IB-IIB carcinoma of the cervix with poor prognostic factors". Anticancer Res., 2000, 20, 2235.